NCT03585712 - Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

April 7, 2020

Study Completion Date

April 7, 2020

Conditions

Contraception

Interventions

DRUG

Norgestrel 0.075 mg

Subjects will take norgestrel 75 mcg every day at the same time for three 28-day treatment periods, except for 1 specific day during treatment period 2 and treatment period 3

Trial Locations (2)

95616

University of California Davis, Sacramento

97239

Oregon Health and Sciences University, Portland